Waters Corporation (WAT)
Waters Corporation (WAT) is a healthcare company (diagnostics & research) based in the United States. The share price is $450.43, down 0.66% on the day, which values the company at $88.52B. Price as of 17 Nov 2026, 17:16 UTC, from Yahoo Finance.
Key facts
- Share price
- $450.43−0.66% today
- Market value
- $88.52B
- P/E ratio
- 188.5×last 12 months
- Forward P/E
- 27.3×
- Funk Score
- 51/100
- Against its own history
- Well above its usual priceusual price $296.43
- 200-week average
- $336.8334% above
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Waters Corporation in more detail
WAT trades at 188.5× its last twelve months' earnings, 27.3× next year's expected earnings, 15.8× sales. Measured against its own history, the price is 52% above what its usual multiples would imply ($296.43) — well above its usual price. It sits 34% above its 200-week average of $336.83.
Over the last five fiscal years Waters Corporation has compounded revenue 6.0% a year, earnings per share 5.2% a year. Its Funk Score is 51 out of 100 (financial strength 7.2, profitability 7.1, growth 4.4, value 1.5, each out of 10).
In its favour: Altman Z in the safe zone; High return on invested capital.
11 of the superinvestors tracked here hold WAT, including Terry Smith (7.7% of the portfolio), Andreas Halvorsen (1.8% of the portfolio), Steven Romick (1.4% of the portfolio).
Superinvestors holding WAT
11 of the investors tracked here report a position in their latest 13F filing.
- Terry Smith Fundsmith7.71% of portfolio · $995.9M · trimmed · Q3 2026
- Andreas Halvorsen Viking Global Investors1.78% of portfolio · $623.4M · added · Q2 2026
- Steven Romick First Pacific Advisors (FPA)1.38% of portfolio · $115.4M · trimmed · Q3 2026
- Nicolai Tangen (founder) AKO Capital0.80% of portfolio · $25.3M · trimmed · Q3 2026
- Brandon Haley Holocene Advisors0.73% of portfolio · $317.9M · trimmed · Q2 2026
- Matthew McLennan First Eagle Investment Management0.65% of portfolio · $416.5M · trimmed · Q3 2026
- Jensen team Jensen Investment Management0.52% of portfolio · $16.5M · trimmed · Q3 2026
- Steve Cohen Point72 Asset Management0.26% of portfolio · $166.6M · added · Q2 2026
- Israel Englander Millennium Management0.23% of portfolio · $335.5M · added · Q2 2026
- David Shaw (founder) D. E. Shaw & Co.0.22% of portfolio · $355.8M · trimmed · Q2 2026
- Bill Nygren Harris Associates (Oakmark)0.01% of portfolio · $6.9M · trimmed · Q2 2026
Health Care companies of similar size
- IDEXX LaboratoriesIDXX
- MedlineMDLN
- HumanaHUM
- Agilent TechnologiesA
- Teva Pharmaceutical IndustriesTEVA
- BeOne MedicinesONC
- NateraNTRA
- IQVIA HoldingsIQV
- Revolution MedicinesRVMD
- Royalty PharmaRPRX
- BiogenBIIB
- GE HealthCare TechnologiesGEHC
Side by side:WAT vs ONC (Waters Corporation vs BeOne Medicines)WAT vs NTRA (Waters Corporation vs Natera)WAT vs IQV (Waters Corporation vs IQVIA Holdings)WAT vs RVMD (Waters Corporation vs Revolution Medicines)WAT vs TEVA (Waters Corporation vs Teva Pharmaceutical Industries)
All health care companies by market valueLargest companies in the United StatesAll stocks A–Z
Waters Corporation (WAT): questions and answers
What is WAT's P/E ratio?
Waters Corporation trades at 188.5× its last twelve months' earnings and 27.3× next year's expected earnings. At its fiscal year-ends over the past 15 years the P/E ranged from 11.4× to 35.3×, with a median of 26.9×.
What is WAT's PEG ratio?
Waters Corporation's PEG ratio is 1.84 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.
What is Waters Corporation's market cap?
Waters Corporation is valued at $88.52B at a share price of $450.43.
Is WAT overvalued or undervalued?
Against its own history, WAT is well above its usual price: the price is 52% above the $296.43 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.
Is WAT above its 200-week moving average?
Yes. WAT is 33.7% above its 200-week average of $336.83. Long-term investors watch that line because strong companies rarely trade below it for long.
How fast is Waters Corporation growing?
Over the last five fiscal years Waters Corporation's revenue grew 6.0% a year and its earnings per share 5.2% a year; over ten years revenue grew 4.5% a year.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Waters Corporation (WAT) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/WAT
Underlying data: Yahoo Finance; company filings with the SEC.